Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine

Details for Australian Patent Application No. 2007248654 (hide)

Owner ANOxA Corp

Inventors Perry, Bryan J.

Agent Watermark

Pub. Number AU-B-2007248654

PCT Pub. Number WO2007/130427

Priority 60/796,263 01.05.06 US

Filing date 1 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 9 December 2010

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/130427 Priority application(s): WO2007/130427

23 April 2009 Assignment before Grant

  Perry, Bryan The application has been assigned to ANOxA Corp

9 December 2010 Application Accepted

  Published as AU-B-2007248654

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248656-Histone deacetylase and tubulin deacetylase inhibitors

2007248647-Stretchable fabric suitable for swimwear applications